Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $8.4 million.

  • Biote's Net Cash Flow fell 2850.01% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.2 million, marking a year-over-year increase of 6277.16%. This contributed to the annual value of -$49.6 million for FY2024, which is 60702.76% down from last year.
  • Latest data reveals that Biote reported Net Cash Flow of $8.4 million as of Q3 2025, which was down 2850.01% from -$22.1 million recorded in Q2 2025.
  • Biote's Net Cash Flow's 5-year high stood at $55.0 million during Q2 2022, with a 5-year trough of -$52.4 million in Q2 2024.
  • Moreover, its 5-year median value for Net Cash Flow was $1.1 million (2024), whereas its average is $573052.6.
  • As far as peak fluctuations go, Biote's Net Cash Flow tumbled by 181205.21% in 2022, and later skyrocketed by 122806.12% in 2023.
  • Over the past 5 years, Biote's Net Cash Flow (Quarter) stood at $3.8 million in 2021, then tumbled by 54.1% to $1.8 million in 2022, then soared by 1228.06% to $23.4 million in 2023, then crashed by 95.21% to $1.1 million in 2024, then surged by 652.18% to $8.4 million in 2025.
  • Its last three reported values are $8.4 million in Q3 2025, -$22.1 million for Q2 2025, and $2.4 million during Q1 2025.